NK cell secreted protein eye drops used for treating viral keratitis as well as preparation method and application thereof
A viral keratitis and NK cell technology, applied in the field of biomedicine, can solve the problems of unclear ingredients, inactivation of active ingredients, and insignificant therapeutic effect, and achieve the effect of obvious effect, not easy to recur, and obvious effect.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0029] The present embodiment provides a method for preparing protein eye drops secreted by NK cells for the treatment of viral keratitis, comprising the following steps:
[0030] Expansion and culture of NK cells:
[0031] 1) Collect 20mL of the patient's own peripheral blood, centrifuge at 200g for 10min, and collect the upper plasma for later use;
[0032] 2) Dilute the blood cells in the lower layer with 2 times the volume of normal saline, then slowly add the diluted blood to the upper layer of the lymphocyte separation medium to make the layers clear, and the volume ratio of the diluted blood to the lymphocyte separation medium is 2:1;
[0033] 3) Centrifuge at 400g for 30min, extract middle buffy coat cells, add normal saline to wash twice, centrifuge at 200g for 5min, and count;
[0034] 4) Add X-VIVO15 serum-free medium to make the cell density 1×10 5 cell / mL, add 5% autologous plasma, 100U / mL IL-2, 100U / mL IL-15, 100U / mL IL-21, 50U / mL CD3 monoclonal antibody;
[0...
Embodiment 2
[0044] The present embodiment provides a method for preparing protein eye drops secreted by NK cells for the treatment of viral keratitis, comprising the following steps:
[0045] Expansion and culture of NK cells:
[0046] 1) Collect 30 mL of the patient's own peripheral blood, centrifuge at 400 g for 10 min, and collect the upper layer of plasma for later use;
[0047] 2) Dilute the blood cells in the lower layer with 2 times the volume of normal saline, then slowly add the diluted blood to the upper layer of the lymphocyte separation medium to make the layers clear, and the volume ratio of the diluted blood to the lymphocyte separation medium is 2:1;
[0048] 3) Centrifuge at 500g for 30min, extract middle buffy coat cells, add normal saline to wash twice, centrifuge at 300g for 5min, and count;
[0049] 4) Add X-VIVO15 serum-free medium to make the cell density 5×10 5 cell / mL, add 5% autologous plasma, 500U / mL IL-2, 500U / mL IL-15, 500U / mL IL-21, 3500U / mL CD3 monoclonal a...
Embodiment 3
[0059] The present embodiment provides a method for preparing protein eye drops secreted by NK cells for the treatment of viral keratitis, comprising the following steps:
[0060] Expansion and culture of NK cells:
[0061] 1) Collect 40 mL of the patient's own peripheral blood, centrifuge at 600 g for 10 min, and collect the upper layer of plasma for later use;
[0062] 2) Dilute the blood cells in the lower layer with 2 times the volume of normal saline, then slowly add the diluted blood to the upper layer of the lymphocyte separation medium to make the layers clear, and the volume ratio of the diluted blood to the lymphocyte separation medium is 2:1;
[0063] 3) Centrifuge at 700g for 30min, extract middle buffy coat cells, wash twice with normal saline, centrifuge at 500g for 5min, and count;
[0064] 4) Add X-VIVO15 serum-free medium to make the cell density 10×10 5 cell / mL, add 5% autologous plasma, 1000U / mL IL-2, 1000U / mL IL-15, 1000U / mL IL-21, 500U / mL CD3 monoclonal ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com